Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cell-surface integrins and collagen-adhesion receptors, including the alpha-v integrin subfamily and discoidin domain receptors (DDR1 and DDR2), are primary mediators of fibroblast interaction with the extracellular matrix (ECM) (Humphries et al., 2019). These receptors are essential for sensing mechanical cues and regulating cell adhesion, migration, and the differentiation of fibroblasts into myofibroblasts during tissue repair (Leask, 2013). In pathological states, their persistent activation drives excessive ECM deposition, leading to organ fibrosis and contributing to the supportive stroma in various cancers (Valiathan et al., 2012). Therapeutic targeting of these receptors aims to interrupt pro-fibrotic signaling, such as the integrin-mediated activation of latent TGF-beta, which is a master regulator of fibrosis (Henderson et al., 2013). While these targets offer significant potential for treating fibroproliferative diseases, their involvement in normal physiological wound healing and tissue maintenance presents a challenge for achieving a favorable therapeutic index (Koivisto et al., 2014).
Inhibition of ligand binding to cell-surface receptors to prevent downstream signaling, reduction of TGF-beta activation, and disruption of fibroblast-to-myofibroblast transition (Henderson et al., 2013; Borradori & Sonnenberg, 1999).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrin and collagen-binding receptor.